Navigating AI Governance: Divergent Paths in US Credit and Medical Device Regulation

This article highlights the critical differences in AI governance between the US consumer financial services and healthcare technology sectors. For internal audit and assurance professionals, understanding these divergent regulatory philosophies is crucial for assessing compliance risks, particularly concerning AI model explainability in credit decisions and adaptive AI in medical devices. The withdrawal of CFPB circulars does not negate statutory obligations, shifting enforcement to a more distributed and complex landscape.